Nabriva Therapeutics Plc

NASDAQ:NBRV   3:23:52 PM EDT
0.19
0.00 (+0.31%)
Earnings Announcements

Nabriva Therapeutics Reports Second Quarter 2022 Financial Results And Provides A Corporate Update

Published: 08/03/2022 21:35 GMT
Nabriva Therapeutics Plc (NBRV) - Nabriva Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update.
Nabriva Therapeutics Plc - Qtrly Net Product Sales of $8.7m Grew 25% Versus Q2 2021.
Revenue is expected to be $11.05 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $13.22 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.